Photoswitchable TCB-2 for control of the 5-HT2A receptor and analysis of biased agonism†
Abstract
Therapies that target the serotonin 2A receptor (5-HT2AR) are promising. However, probes are needed to better understand the role of 5-HT2AR. Here, we design and synthesize a photoswitch and photoswitchable 5-HT2AR ligand based on highly potent agonist TCB-2 and arylazopyrazole, which also boasts photoswitchable G protein vs. β-arrestin pathway bias.
- This article is part of the themed collection: 2024 Emerging Investigators